INFINITY PHARMA
Holdings
own 2025 accountsThis companyINFINITY PHARMA3 holdings, 1 country
2025 accounts
Belgium 3 Equity Result
- BE €35.9m result €1.0m
- BE €1.7m result -€1.4m
- BE €1.3m result €833,622
Source: list of holdings in its own 2025 accounts. Every holding stands with its own latest accounts.
Parent
Belgium · equity €573.3m · profit €50.0m (2025)
At the same address
Venecoweg 20A, 9810 Nazareth-De Pinte · 4 other companies| FAGRON
registered office since 03-07-2007 · founded in 2007 |
total assets €606.0m (2025) 0890.535.026 |
| FAGRON CAPITAL
registered office since 06-06-2000 · founded in 2000 |
total assets €461.1m (2025) 0471.941.919 |
| ABC DENTAL AND PHARMACEUTICAL CONSULTANCY
registered office since 26-03-1991 · founded in 1990 |
total assets €36.0m (2025) 0442.286.247 |
| FAGRON BELGIUM
registered office since 22-11-2001 · founded in 1959 |
57 FTE (2025) 0403.767.052 |
Earlier ties
Of the 6 companies once linked to INFINITY PHARMA, 2 have negative equity and 1 is late with its accounts.
via , at INFINITY PHARMA until 2007 · Director · deed of 16-03-2017 founded in 1983 · accounts filed late |
9 FTE (2024) |
via , at INFINITY PHARMA until 2017 · Director · deed of 09-02-2021 founded in 2015 · negative equity (2025) |
16 FTE (2025) |
via , at INFINITY PHARMA until 2007 · Director (not named in the articles) · deed of 08-01-2024 founded in 2006 · negative equity (2025) |
total assets €5,994 (2025) |
via , at INFINITY PHARMA until 2007 · Director · deed of 08-10-2013 founded in 2000 |
total assets €461.1m (2025) |
via , at INFINITY PHARMA until 2017 · Permanent representative · deed of 19-05-2020 founded in 1996 |
237 FTE (2025) |
via , at INFINITY PHARMA until 2017 · Permanent representative · deed of 05-01-2024 founded in 2018 |
total assets €159.1m (2025) |
Holdings and subsidiaries
3 holdingsHoldings 3
Share, source and own figures per holding (3)
Source for every holding own accounts 2025
- subsidiaryEquity €1.7m Loss of €1.4m in 2025 (loss of €1.9m in 2024) Checked scoreAlsoaccounts 2025100%
- subsidiaryEquity €1.3m Profit of €833,622 in 2025 (profit of €263,263 in 2024) Checked scoreAlsoaccounts 2025100%
- Equity €35.9m Profit of €1.0m in 2025 (profit of €1.3m in 2024) Checked scoreAlsoaccounts 20250.01%
Former holdings (6)
- was absorbed by INFINITY PHARMA on 29-11-2018.That merger ended this holding.Sourcedeed 27-12-2018100%
- was absorbed by INFINITY PHARMA on 16-07-2020.That merger ended this holding.Sourcedeed 13-08-2020100%
- was absorbed by INFINITY PHARMA on 29-11-2018.That merger ended this holding.Sourcedeed 27-12-2018100%
- was absorbed by INFINITY PHARMA on 03-06-2021.That merger ended this holding.Sourcedeed 26-07-2021100%
- was absorbed by INFINITY PHARMA on 21-06-2023.That merger ended this holding.Sourcedeed 08-08-2023100%
-
100%
Acquisitions and mergers
8 transactionsTook over:PHARMA-PACK
Took over:Infinity Pharma
Took over:ARSEUS BELGIË
Took over:BELGOPHAR
Took over:EUPHACO
Show 2 more transactions
Took over:A.C.A.-PHARMA
Took over:VERRERIE VERVIÉTOISE
Connections & network
This company
Company
Director
Shareholding
+N: links not shown yet
Bankruptcy, dissolution or liquidation
Click a node to look further, drag to arrange, zoom with the mouse wheel.